Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Feb 21, 2020; 26(7): 749-758
Published online Feb 21, 2020. doi: 10.3748/wjg.v26.i7.749
Table 3 Univariate and multivariate analyses of prognostic factors for overall survival and recurrence-free survival
VariablesOverall survival
Recurrence-free survival
Univariate
Multivariate
Univariate
Multivariate
P valueHR (95%CI)P valueP valueHR (95%CI)P value
Sex (M/F)0.5950.962
Age (> 50/< 50 yr)0.0201.853 (1.243-2.761)0.0020.071
BMI (≥ 24/<24 kg/m2)0.5960.770
Cause of hepatitis (HBV/HCV/others)0.2690.422
ALT (> 40/≤ 40 U/L)0.2550.069
AFP (≥ 400/< 400 μg/L)0.1110.092
INR (≥ 1.3/< 1.3)< 0.0010.009
PLT (≥ 100/< 100 × 109/L)0.3920.713
Number of tumors (single/≥ 2)0.2430.065
Tumor size (≥ 5/< 5 cm)< 0.001< 0.001
Blood transfusion (yes/no)0.0010.003
Surgical bleeding (> 400/≤ 400 mL)0.0050.0031.437 (1.004-2.058)0.048
Types of liver resection (minor/major)< 0.001< 0.001
Intraoperative radiotherapy and/or chemotherapy (yes/no)0.6490.430
PVTT (yes/no)< 0.0010.005
Capsule formation (yes/no)0.4080.374
Differentiation (good/poor)0.0042.230 (1.452-3.426)< 0.0010.029
PH (yes/no)0.8090.542
Liver cirrhosis (yes/no)0.9440.896
Child-Pugh grade (A/B)< 0.0010.001
BCLC stage (0 or A/B/C)< 0.001< 0.001
0 or A11
B2.635 (1.235-5.622)0.0122.246 (1.095-4.607)0.027
ALBI grade (1/2/3)< 0.0010.003
MCP grade< 0.001< 0.001
111
21.864 (1.174-2.959)0.0081.830 (1.246-2.687)0.002
32.005 (1.071-3.753)0.030